Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Federal Trade Commission
Chinese Patent Office
Express Scripts
Boehringer Ingelheim
AstraZeneca
McKinsey
Farmers Insurance

Generated: April 20, 2018

DrugPatentWatch Database Preview

PAMELOR Drug Profile

« Back to Dashboard

When do Pamelor patents expire, and when can generic versions of Pamelor launch?

Pamelor is a drug marketed by Specgx Llc and is included in two NDAs.

The generic ingredient in PAMELOR is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Drug patent expirations by year for PAMELOR
Pharmacology for PAMELOR
Medical Subject Heading (MeSH) Categories for PAMELOR
Synonyms for PAMELOR
(2)10,11-Dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-.delta.5.gamma.-propylamine
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methyl-
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[ a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-
10,11-Dihydro-5-(3-methylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptene
10,11-Dihydro-5-(3-methylaminopropylidene)-5H-dibenzo[a,d][1,4]cycloheptene
10,11-Dihydro-N-methyl-5H-dibenzo(a,d)cycloheptane-.DELTA.,.gamma.-propylamine
10,11-Dihydro-N-methyl-5H-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamine
10,11-dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-Delta(5,gamma)-propylamine
21B
3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methylpropylamine
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine
3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine
3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methylpropylamine
3-(5,6-dihydrodibenzo[[?],[?]][7]annulen-11-ylidene)-N-methyl-propan-1-amine
5-(3-(Methylamino)propylidene)dibenzo(a,e)cyclohepta(1,5)diene
5-(3-Methylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(alpha-Methylaminopropylidene)dibenzo(a,d)cyclohepta(1,4)diene
5-[3-(Methylamino)propylidene]dibenzo[a,E]cyclohepta[1,5]diene
5H-Dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine, 10,11-dihydro-N-methyl-
5H-Dibenzo[a,d]cycloheptene-.DELTA.5,.gamma.-propylamine, 10,11-dihydro-N-methyl-
72-69-5
AB00052061
AB00052061_16
AC1L1IED
Acetexa
AKOS022507396
Allegron
Allegron (TN)
Altilev
Amitryptyline, demethyl-
AN-22230
API0003635
Ateben
Ateben hydrochloride
Avantyl
Aventyl
Aventyl (TN)
Aventyl allegron
AVENTYL HCL
Aventyl hydrochloride
BDBM112777
BIDD:PXR0187
BL03SY4LXB
BPBio1_000076
BRD-K91263825-003-03-2
BRN 2216786
BSPBio_000068
BSPBio_002111
C07274
CAS-894-71-3
CCG-38266
CCRIS 9175
CHEBI:7640
CHEMBL445
D04WFD
D08288
DB00540
Demethylamitriptylene
demethylamitriptylin
Demethylamitriptyline
Demethylamitryptyline
Desitriptilina
Desitriptyline
Desmethylamitriptylin
Desmethylamitriptyline
DivK1c_000151
DTXSID9023384
EINECS 200-788-8
EN300-57709
GTPL2404
HMS1920B20
HMS2091J20
HMS500H13
HSDB 3371
IDI1_000151
KBio1_000151
KBio2_001521
KBio2_004089
KBio2_006657
KBio3_001611
KBioGR_000870
KBioSS_001521
KSC-315-028-
KUC112478N
Lilly 38489
Lopac-N-7261
Lopac0_000868
LS-60753
Lumbeck
methyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-ylidene]propyl})amine
methyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine
methyl({3-[(2E)-tricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine
METHYL(3-{TRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE}PROPYL)AMINE
MRF-0000480
N-Methyl-3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)propylamin
NCGC00014483
NCGC00014483-02
NCGC00014483-03
NCGC00014483-04
NCGC00014483-05
NCGC00014483-06
NCGC00014483-07
NCGC00014483-08
NCGC00014483-09
NCGC00014483-10
NCGC00014483-11
NCGC00014483-12
NCGC00024261-03
NCGC00024261-04
NCGC00024261-05
NCGC00024261-06
NCI169453
NCI60_001354
NCIOpen2_004361
NCIStruc1_000856
NCIStruc2_000700
NINDS_000151
Noramitriptyline
Noritren
Norpress (TN)
Nortab hydrochloride
Nortrilen
Nortrilen (TN)
Nortriptilina
Nortriptilina [DCIT]
Nortriptylene hydrochloride
Nortriptylin hydrochloride
nortriptylina
nortriptyline
Nortriptyline (INN)
Nortriptyline [INN:BAN]
Nortriptyline Hcl
Nortriptylinum
Nortriptylinum [INN-Latin]
Nortryptiline
Nortryptyline
Norzepine
NSC-169453
NSC-757234
NSC169453
NSC757234
NSC78248
Pamelor (TN)
Pamelor hydrochloride
PDSP1_001805
PDSP2_001788
Pharmakon1600-01500442
PHVGLTMQBUFIQQ-UHFFFAOYSA-N
PL004577
Prestwick0_000254
Prestwick1_000254
Prestwick2_000254
Prestwick3_000254
Psychostyl
Psychostyl (Salt/Mix)
QTL1_000063
SBI-0050843.P004
SCHEMBL34527
Sensaval
Sensival
Sensival Ventyl
Sensoval (TN)
Sesaval
SPBio_001093
SPBio_002287
Spectrum_001041
SPECTRUM1500442
Spectrum2_000997
Spectrum3_000526
Spectrum4_000455
Spectrum5_001377
UNII-BL03SY4LXB
US8629135, SW-02
Vividyl
ZINC1530741

US Patents and Regulatory Information for PAMELOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-004 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PAMELOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride SOLUTION;ORAL 018012-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Accenture
Cipla
UBS
Deloitte
Colorcon
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.